Annexes to COM(2020)814 - Position of the EU in the Commission on Narcotic Drugs on the scheduling of substances under the Conventions on Narcotic Drugs and on Psychotropic Substances - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
| dossier | COM(2020)814 - Position of the EU in the Commission on Narcotic Drugs on the scheduling of substances under the Conventions on Narcotic ... |
|---|---|
| document | COM(2020)814  |
| date | December 17, 2020 |
(6) Commission Delegated Directive (EU) 2020/1687 of 2 September 2020 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of ‘drug’, OJ L 379, 13.11.2020, p. 55.
(7) COM(2017) 72 final; COM(2018) 31 final; COM(2018) 862 final; COM(2019) 631 final.
(8) Adopted by the Council on 7 March 2017, on 27 February 2018, on 5 March 2019, and on 11 February 2020, respectively.
(9) Judgment of the Court of Justice of 7 October 2014, Germany v Council, C-399/12, ECLI:EU:C:2014:2258, paragraph 64.
(10) Judgment of the Court of Justice of 7 October 2014, Germany v Council, C-399/12, ECLI:EU:C:2014:2258, paragraphs 61 to 64.
(11) Article 3(7) of the Convention on Narcotic Drugs; Article 2(7) of the Convention on Psychotropic Substances.
(12) United Nations Treaty Series, vol. 978, No. 14152.
(13) United Nations Treaty Series, vol. 1019, No. 14956.
(14) Council Framework Decision 2004/757/JHA of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking (OJ L 335, 11.11.2004, p. 8).
(15) Austria, Belgium, Croatia, Czech Republic, France, Germany, Hungary, Italy, Netherlands, Poland, Spain and Sweden.
(16) Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (OJ L 376, 27.12.2006, p. 1).
(17) Commission Delegated Directive (EU) 2020/1687 of 2 September 2020 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of ‘drug’, C(2020) 5897 final, OJ L 379, 13.11.2020, p. 55.